3,891 results on '"leukemia"'
Search Results
2. Natural killer cell cytotoxicity shapes the clonal evolution of B cell leukaemia (Updated October 21, 2024)
3. Findings from Dana-Farber Cancer Institute Yields New Findings on Escherichia coli (Non-pathogenic e. Coli Displaying Decoy-resistant Il18 Mutein Boosts Anti-tumor and Car Nk Cell Responses)
4. JunB-HBZ nuclear translocation by TGF-beta is a key driver in HTLV-1-mediated leukemogenesis
5. JunB-HBZ nuclear translocation by TGF-b is a key driver in HTLV-1-mediated leukemogenesis (Updated October 8, 2024)
6. Profiling drug sensitivity of leukemic stem cells via bulk-to-single-cell deconvolution (Updated October 1, 2024)
7. Recent Findings from Jackson Laboratory Has Provided New Information about Leukemia (Hematopoietic Stem Cell Aging and Leukemia Transformation)
8. Patent Application Titled 'Tobacco Mosaic Virus Delivery Of Mitoxantrone For Cancer Therapy' Published Online (USPTO 20240285793)
9. FGR Src Family Kinase Causes Signaling and Phenotypic Shift Mimicking Retinoic Acid-Induced Differentiation of Leukemic Cells
10. Tunnelling nanotubules are druggable mediators of cancer-niche crosstalk. (Updated August 16, 2024)
11. The Clonal Hematopoiesis-associated Gene Srcap Plays an Essential Role in Hematopoiesis
12. National Institute for Environmental Studies Researcher Adds New Data to Research in Promyelocytic Leukemia (Behavior of Assembled Promyelocytic Leukemia Nuclear Bodies upon Asymmetric Division in Mouse Oocytes)
13. KMT2A oncoproteins induce epigenetic resistance to targeted therapies (Updated August 12, 2024)
14. Research Reports on Neuroblastomas from Institute of Biology and Earth Sciences Provide New Insights (Curcumin's membrane localization and disruptive effects on cellular processes - insights from neuroblastoma, leukemic cells, and Langmuir ...)
15. Research from JSS Academy of Higher Education and Research Yields New Data on Cancer (Synthesis, characterization, and anti-cancer potential of novel p53-mediated Mdm2 and Pirh2 modulators: an integrated In silico and In vitro approach)
16. Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance
17. Dynamic Localization of Leukemia Stem Cells via CXCL12 Regulates Leukemia Progression
18. Genomic evidence of Escherichia coli gut population diversity translocation in leukemia patients
19. Researchers from Cleveland Clinic Report Details of New Studies and Findings in the Area of Hematopoiesis (Clonal Hematopoiesis-derived Therapy-related Myeloid Neoplasms After Autologous Hematopoietic Stem Cell Transplant for Lymphoid and ...)
20. Reports from Ancona Describe Recent Advances in Cancer (FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets)
21. Repair of leukemia-associated single nucleotide variants via interallelic gene conversion
22. Researchers at Icahn School of Medicine at Mount Sinai Have Reported New Data on Hematology (Discovery of a Novel, Highly Potent Ezh2 Protac Degrader for Targeting Non-canonical Oncogenic Functions of Ezh2)
23. Ascorbate depletion increases quiescence and self-renewal potential in hematopoietic stem cells and multipotent progenitors
24. Susan G. Komen® and Walgreens Mark 5 Years of Impact, Surpassing $37 Million in Cancer Support
25. Research on Leukemia Discussed by Researchers at University of Oxford (Aberrant stem cell and developmental programs in pediatric leukemia)
26. Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators
27. Study Findings on Leukemia Described by Researchers at Sun Yat-sen University (Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins)
28. Studies from Emory University in the Area of Solid Cancer Reported (Engineering Improved Car T Cell Products With a Multi-cytokine Particle Platform for Hematologic and Solid Tumors)
29. New Cancer Study Findings Has Been Reported by a Researcher at Medical University of Warsaw (Lactoferricin B Combined with Antibiotics Exhibits Leukemic Selectivity and Antimicrobial Activity)
30. Escherichia coli extra-intestinal population translocation in leukemia patients
31. High interleukin-3 concentrations prime murine myeloid progenitor cells towards granulocytic differentiation
32. Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition (Updated January 10, 2024)
33. Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A
34. A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Eliminates Ex Vivo Reservoirs
35. Researcher from Kumamoto University Provides Details of New Studies and Findings in the Area of Adult T-Cell Leukemia-Lymphoma (Effect of Viral Antigen Mismatch on Antiviral T-Cell Response and Immunotherapeutic Efficacy Against Adult T-Cell ...)
36. Researchers Submit Patent Application, 'Small Molecule Inhibition Of Deubiquitinating Enzyme Josephin Domain Containing 1 (Josd1) As A Targeted Therapy For Leukemias With Mutant Janus Kinase 2 (Jak2)', for Approval (USPTO 20240335427)
37. Genomic Discovery of EF-24 Targets Unveils Antitumorigenic Mechanisms in Leukemia Cells
38. Patent Application Titled 'Targeting Dot1l And Smarca4/2 For The Treatment Of Mllr Leukemia' Published Online (USPTO 20240335438)
39. Patent Application Titled 'Tinostamustine For Use In The Treatment Of T-Cell Prolymphocytic Leukaemia' Published Online (USPTO 20240316009)
40. Patent Issued for Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy (USPTO 12091681)
41. Leukemia-derived apelin selects endothelial niche clones to promote tumorigenesis
42. Blood Donations Are Needed for Those Battling Cancer
43. The Human T-cell Leukemia Virus capsid protein is a potential drug target
44. Studies from City of Hope National Medical Center Further Understanding of Drug Research (The Role of Signaling Lymphocyte Activation Molecule Family Receptors In Hematologic Malignancies)
45. New Prolymphocytic Leukemia Study Findings Have Been Reported from Department of Oncology (Acute Coronary Syndrome as an Unusual Initial Presentation of T-Prolymphocytic Leukemia: A Case Report and Review of the Literature)
46. Study Data from National Institute of Health Provide New Insights into Myeloma (Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview)
47. Reports on Hematology from University of Colorado Provide New Insights (Chip: a Clonal Odyssey of the Bone Marrow Niche)
48. Cleveland Clinic Researchers Describe Recent Advances in Leukemia (* * KMT2A* * Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives)
49. New Findings from Munich Leukemia Laboratory Update Understanding of Monocytosis (Comparing Malignant Monocytosis Across the Updated Who and Icc Classifications Fi Cations of 2022)
50. Tel Aviv University Researchers Update Knowledge of Leukemia (The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.